The early detection and differential diagnosis of respiratory infections increase the chances
for successful control of COVID-19 disease. The nucleic acid RT-PCR test is regarded as the …

Hundreds of RT-qPCR kits are available in the market for SARS-CoV-2 diagnosis, some of
them with emergency use authorization (EUA) by the Food Drug Administration (FDA) or …

Background SARS-CoV-2 nucleic acid detection by RT-PCR is one of the criteria approved
by China FDA for diagnosis of COVID-19. However, inaccurate test results (for example …

Abstract The World Health Organization has reported approximately 430 million confirmed
cases of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory …

Abstract Corona Virus Disease 2019 (COVID-19) is a recently emerged life-threatening
disease caused by SARS-CoV-2. Real-time fluorescent PCR (RT-PCR) is the clinical …

Real-time reverse transcription polymerase chain reaction (RT-qPCR) is the most sensitive
and specific assay and, therefore, is the “gold standard” diagnostic method for the diagnosis …

At the start of the COVID-19 pandemic, the Centers for Disease Control and Prevention
(CDC) designed, manufactured, and distributed the CDC 2019-Novel Coronavirus (2019 …

The outbreak of the new human coronavirus SARS-CoV-2 (also known as 2019-nCoV)
continues to increase globally. The real-time reverse transcription polymerase chain …

Abstract Coronavirus disease 2019 (COVID-19) is newly emerging human infectious
diseases, which is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS …

SARS-CoV-2 is very contagious and has rapidly spread globally. Due to various
symptomatic and asymptomatic cases and the possibility of asymptomatic transmission …